Association systolic blood pressure with intracranial complications and mortality hospital in patients with subarachnoid hemorrhage Fisher IV

Netzahualcóyotl González Pérez; Sandra Porcayo Liborio; Erika Rivera Duron

2016, Number 3

<< Back Next >>

Med Crit 2016; 30 (3)

Association systolic blood pressure with intracranial complications and mortality hospital in patients with subarachnoid hemorrhage Fisher IV

González PN, Porcayo LS, Rivera DE

Full text

How to cite this article

Language: Spanish
References: 11
Page: 183-186
PDF size: 154.15 Kb.

ABSTRACT

Introduction: The magnitude of the control of blood pressure to reduce the risk of intracranial complications and mortality in aneurysmal subarachnoid hemorrhage (aASH) of high degree is underestimated.
Hypothesis: Systolic blood pressure (SBP) greater than 160 mmHg is associated with the presence of intracranial complications and hospital mortality in patients with HSAA Fisher IV.
Objective: To analyze the association of SBP with the presence of intracranial complications and hospital mortality in patients with aASH Fisher IV.
Material and methods: An observational, retrospective, comparative, from August 2014 to September 2015. Were 36 patients with aASH Fisher IV admitted to the unit neurocritical of the National Institute of Neurology and Neurosurgery, forming two groups, based on SBP higher or lower than 160 mmHg, the association of intracranial complications was identified using the chi-square and the likelihood of individual survival accumulated in the days of hospital stay with the Kaplan-Meier method was calculated by verifying Long Rank test statistical significance.
Conclusion: In aASH Fisher IV as SBP greater than 160 mmHg is associated with rebleeding (p = 0.05) and lower survival (p = 0.04).

REFERENCES

Cahill WJ, Calvert JH, Zhang JH. Mechanisms of early brain injury after subarachoid hemorrhage. Journal of Cerebral Blood Flow and Metabolism. 2006;26:1341-1353.
Schievink WI, Wijdicks EF, Parisi JE, Piepgras DG, Whisnant JP. Sudden death from aneurysmal subarachnoid hemorrhage. Neurology. 1995;45:871-874.
Cannolly ES. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage. American Heart Association. 2012.
De Rooij NK, Linn FH, Van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365-1372.
Claassen J, et al. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke. 2002;33:1225-1232.
Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38:2315-2321.
Naidech AM, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005;62:410-416.
Ransom ER, et al. External ventricular drainage response in poor grade aneurysmal subarachnoid hemorrhage: effect on preoperative grading and prognosis. Neurocrit Care. 2007;6:174-180.
Simard J M. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6:258-68.
Vergouwen MD, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391-2395.
Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010;14:R23.